154 related articles for article (PubMed ID: 35071044)
1. Vaccine Protection of Mice With Primary Immunodeficiencies Against Disseminated Coccidioidomycosis.
Powell DA; Hsu AP; Butkiewicz CD; Trinh HT; Frelinger JA; Holland SM; Galgiani JN; Shubitz LF
Front Cell Infect Microbiol; 2021; 11():790488. PubMed ID: 35071044
[TBL] [Abstract][Full Text] [Related]
2. Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
Shubitz LF; Robb EJ; Powell DA; Bowen RA; Bosco-Lauth A; Hartwig A; Porter SM; Trinh H; Moale H; Bielefeldt-Ohmann H; Hoskinson J; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2021 Nov; 39(47):6894-6901. PubMed ID: 34696935
[TBL] [Abstract][Full Text] [Related]
3. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
4. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
5. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
6. A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.
Narra HP; Shubitz LF; Mandel MA; Trinh HT; Griffin K; Buntzman AS; Frelinger JA; Galgiani JN; Orbach MJ
Infect Immun; 2016 Oct; 84(10):3007-16. PubMed ID: 27481239
[TBL] [Abstract][Full Text] [Related]
7. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against
Campuzano A; Zhang H; Ostroff GR; Dos Santos Dias L; Wüthrich M; Klein BS; Yu JJ; Lara HH; Lopez-Ribot JL; Hung CY
J Immunol; 2020 Jun; 204(12):3296-3306. PubMed ID: 32358020
[No Abstract] [Full Text] [Related]
8. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
Fierer J; Waters C; Walls L
J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
[TBL] [Abstract][Full Text] [Related]
9. Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).
Hung CY; Gonzalez A; Wüthrich M; Klein BS; Cole GT
Infect Immun; 2011 Nov; 79(11):4511-22. PubMed ID: 21859851
[TBL] [Abstract][Full Text] [Related]
10. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
12. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
[TBL] [Abstract][Full Text] [Related]
13. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
Hung CY; Wozniak KL; Cole GT
Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
[TBL] [Abstract][Full Text] [Related]
15. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
16. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
17. Dectin-1 is required for resistance to coccidioidomycosis in mice.
Viriyakosol S; Jimenez Mdel P; Gurney MA; Ashbaugh ME; Fierer J
mBio; 2013 Feb; 4(1):e00597-12. PubMed ID: 23386437
[TBL] [Abstract][Full Text] [Related]
18. A Chronic Murine Disease Model of Coccidioidomycosis Using Coccidioides posadasii, Strain 1038.
Shubitz LF; Powell DA; Butkiewicz CD; Lewis ML; Trinh HT; Frelinger JA; Orbach MJ; Galgiani JN
J Infect Dis; 2021 Jan; 223(1):166-173. PubMed ID: 32658292
[TBL] [Abstract][Full Text] [Related]
19. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
[TBL] [Abstract][Full Text] [Related]
20. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
Hurtgen BJ; Hung CY
Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
